| Mark A. Velleca, M.D., Ph.D. | President and Chief Executive Officer | FY2025 | |
| Sergey Yurasov, M.D., Ph.D. | Chief Medical Officer | FY2025 | |
| Brent Hatzis-Schoch, Esq. | Chief Operating Officer and General Counsel | FY2025 |
3 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.